Filana Therapeutics, Inc. Debt Securities, Available-for-sale
Filana Therapeutics, Inc. (FLNA) had Debt Securities, Available-for-sale of $20.44 million as of 2018-09-30, per its 10-Q filed 2018-10-30.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2018-10-30
- 2018-09-30: Debt Securities, Available-for-sale $20.44M.
- 2018-06-30: Debt Securities, Available-for-sale $9.61M.
- 2018-03-31: Debt Securities, Available-for-sale $10.73M.
- 2017-12-31: Debt Securities, Available-for-sale $10.48M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2018-09-30 | $20.44M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $9.61M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $10.73M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $10.48M 10-Q · filed 2018-10-30 |
| 2017-09-30 | $11.92M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $14.07M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $17.26M 10-Q · filed 2017-04-26 |
| 2016-12-31 | $18.71M 10-K · filed 2018-02-06 |
| 2016-09-30 | $21.76M 10-Q · filed 2016-10-26 |
| 2016-06-30 | $24.63M 10-Q · filed 2016-07-19 |
| 2016-03-31 | $28.11M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $31.30M 10-K · filed 2017-03-07 |
| 2015-09-30 | $34.89M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $37.30M 10-Q · filed 2015-07-23 |
| 2015-03-31 | $39.25M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $40.59M 10-K · filed 2016-03-03 |
| 2014-09-30 | $43.15M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $44.83M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $47.10M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $49.84M 10-K · filed 2015-02-18 |
| 2013-09-30 | $51.03M 10-Q · filed 2013-11-01 |
| 2013-06-30 | $52.84M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $54.39M 10-Q · filed 2013-04-24 |
| 2012-12-31 | $56.25M 10-K · filed 2014-02-05 |
| 2012-09-30 | $92.53M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $93.94M 10-Q · filed 2012-08-02 |
| 2011-12-31 | $98.13M 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |